Cannabis and Hemp Industry Investment News
Also on the move were Cannabis One, Golden Leaf, Isodiol, MedMen, Tilray and Green Growth Brands Canntab shares lit up after it announced a deal for c...
What are you searching for? viewCanntab Therapeutics Ltd () President and CEO Clint Sharples and Canntab Therapeutics () CFO Richard Goldstein joined ...
Heritage's subsidiary Purefarma Solutions will take hemp from Canntab for the purpose of processing it into high-quality CBD oil Canntab is best known...
What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics Limited (CSE:PILL.CN) (OTCMKTS:CTABF) CFO Richard Goldstein tells Proact...
Also on the move were PreveCeutical, The Supreme Cannabis Company, Cronos, Golden Leaf Holdings and Isodiol International Canntab is the first to offe...
What are you searching for? viewCanntab Therapeutics Ltd Buds of the day are (CSE:PILL.CN) (OTCMKTS:CTABF), () (OTCMKTS:PRVCF). The duds are () (), ...
Canntab intends to use the licence to secure large amounts of hemp biomass that it will use to extract cannabidiol (CBD) to manufacture cannabis pills...
What are you searching for? viewCanntab Therapeutics Ltd Buds today are Canntab Therapeutics Limited () (OTQX:CTABF), Curaleaf Holdings () (OTCMKTS:CU...
Also on the move were Curaleaf, The Green Organic Dutchman Holdings, Sunniva, CannTrust and TILT Canntab is the first to offer medical cannabis in pil...
CEO Jeff Renwick says the move aligns with the company’s goal to be a ‘global leader’ of research and production in hard pill oral dosage therapeutic ...
Canntab Therapeutics (CSE:PILL-OTCQB:CTABF) CFO Richard Goldstein joined Steve Darling from Proactive Investors Vancouver on Skype to discuss their pa...
FSD’s new sales license allows Canntab to produce samples of CBD-containing capsules, which will enable the company to begin production and sales from...
What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics () CFO Richard Goldstein joined Steve Darling from Proactive Investors V...
The trio of companies will buy up to C$5 million of Thomas Elcome’s hemp crop for five years starting in 2019 The three companies earlier struck a dea...
Canntab Therapeutics () Chief Financial Officer Richard Goldstein sat down with Steve Darling from Proactive Investors Vancouver to discuss the news t...
A placebo-controlled study led by Dr Don Garbuz will test the effectiveness of the company’s Canntab product in reducing the need for opioids after kn...
The company said it reached a milestone in its development of an oral extended-release formulation for cannabinoids Canntab has taken an important ste...
The company is developing advanced pharmaceutical grade formulations of cannabinoids The company is developing advanced pharmaceutical grade formulati...
What are you searching for? viewCanntab Therapeutics Ltd . () CFO Richard Goldstein checked in with Steve Darling from Proactive Investors on Skype to...
The company on Wednesday said it had inked a non-binding Letter of Intent (LOI) with Labsco Promedic SA de CV Canntab is making inroads into Mexico Po...
